Zobrazeno 1 - 10
of 14 095
pro vyhledávání: ''
Publikováno v:
Experimental Physiology, Vol 109, Iss 7, Pp 1124-1133 (2024)
Abstract Media supplemented with sera from acutely exercised men has been shown to have ‘anti‐cancer’ effects on prostate and breast cancer cell lines. This study investigated whether media supplemented with plasma samples taken at rest (≥30
Externí odkaz:
https://doaj.org/article/90d2be6127484f81916b822215a122f7
Publikováno v:
Precision Medical Sciences, Vol 13, Iss 2, Pp 99-106 (2024)
Abstract p95HER2 isoform is a truncated form of HER2 that retains the C terminal domain but lacks an N terminal trastuzumab binding site. From 2014 to 2016, we assessed the expression of p95HER2 expression in 59 HER2‐positive breast cancer patients
Externí odkaz:
https://doaj.org/article/7a951ce7c1964f599d6ca482e974327a
Publikováno v:
Thoracic Cancer, Vol 15, Iss 17, Pp 1357-1368 (2024)
Abstract Background Berberine (BBR), an isoquinoline alkaloid from Coptidis rhizoma, has been found to have powerful activities against various human malignancies, including breast cancer. However, the underlying antitumor mechanisms of BBR in breast
Externí odkaz:
https://doaj.org/article/53cf59590ce148e0ba67fc2e510f9f6f
Autor:
Carmen Cantisani, Federica Trovato, Luca Gargano, Antonio Di Guardo, Alexandru Bâja Vasile, Emanuele Rovaldi, Giulia Azzella, Iolanda Speranza, Giuseppe Soda, Michela Roberto, Tiziana Lettera, Giovanni Pellacani
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 2, Pp 687-692 (2024)
Abstract Breast cancer represents the most common malignancy in women worldwide. In most cases, metastasis is the leading cause of mortality. Early diagnosis is still challenging despite standardised, government‐led screening programs, but is cruci
Externí odkaz:
https://doaj.org/article/bb4c8b238e0746239cac7ec2f4633d38
Autor:
Liang‐Zi Zhang, Qi‐Cheng Sun, Hang‐Hang Luan, Qian‐Qian Yuan, Tong Deng, Li‐Sha Luo, Xiao‐Lin Tan
Publikováno v:
Thoracic Cancer, Vol 15, Iss 16, Pp 1279-1286 (2024)
Abstract Background This study aims to analyze breast cancer burden attributable to high body mass index (BMI) and high fasting plasma glucose (FPG) in China from 1990 to 2019. Methods Data were obtained from the Global Burden of Disease (GBD) study
Externí odkaz:
https://doaj.org/article/53818425e0194a588d3a6b1f9eb1328a
Publikováno v:
Thoracic Cancer, Vol 15, Iss 14, Pp 1132-1137 (2024)
Abstract Background The simultaneous (synchronous) presence of primary breast cancer and primary lung cancer diagnosed in a single individual is not an uncommon phenomenon. However, reference data for treatment strategy is scarce and “chaotic”. I
Externí odkaz:
https://doaj.org/article/b7025a538d4c420181b9cb850374a32b
Publikováno v:
FEBS Open Bio, Vol 14, Iss 5, Pp 831-842 (2024)
The important role of cholesterol in tumor metastasis has been widely studied in recent years. Ezetimibe is currently the only selective cholesterol uptake inhibitor on the market. Here, we explored the effect of ezetimibe on breast cancer metastasis
Externí odkaz:
https://doaj.org/article/9906a4dead6545c3a078f3aee43cd169
Publikováno v:
Thoracic Cancer, Vol 15, Iss 12, Pp 974-986 (2024)
Abstract Background The causal relationship between breast cancer (BC) and the oral microbiome remains unclear. In this case–control study, using two‐sample Mendelian randomization (MR), we thoroughly explored the relationship between the oral mi
Externí odkaz:
https://doaj.org/article/4f1f09e3fdd949a594c23f33144a1074
Autor:
Siyao Mai, Haiqing Liu, Hong Zeng, Ziliang Cheng, Jingwen Huang, Guangzi Shi, Yong Li, Zhuo Wu
Publikováno v:
Thoracic Cancer, Vol 15, Iss 12, Pp 1017-1028 (2024)
Abstract Background The aim of this study was to compare breast cancer patients with pulmonary oligometastases (POM) and primary lung cancer (PLC) and to assess whether there were differences in clinical features, CT features, and survival outcomes b
Externí odkaz:
https://doaj.org/article/f866abcd14664635bbfece790bb1b419
Publikováno v:
Thoracic Cancer, Vol 15, Iss 10, Pp 820-829 (2024)
Abstract Background N‐acetyltransferase 10 (NAT10) serves as a critical enzyme in mediating the N4‐acetylcytidine (ac4C) that ensures RNA stability and effective translation processes. The role of NAT10 in driving the advancement of breast cancer
Externí odkaz:
https://doaj.org/article/1794259c33cc450b874f64ee7cca54ba